CJC-1295 W/O DAC 10mg

KEY BENEFITS

• Supports research into natural growth hormone (GH) release through GHRH pathway signaling

• Short-acting format allows study of rapid and pulse-based GH response patterns

• Commonly explored for recovery and performance-related endocrine research

• Frequently used in research models focused on the hypothalamic–pituitary axis

• Often selected when tighter timing and control of GH signaling is desired

Full Description

CJC-1295 (without DAC) is a synthetic peptide based on a growth hormone–releasing hormone (GHRH) fragment. In laboratory and pre-clinical research, it is used to stimulate the pituitary to release endogenous growth hormone through the body’s natural signaling pathway.

Unlike long-acting versions, CJC-1295 without DAC is short-acting, which makes it well suited for research models that focus on growth hormone pulsatility and timing of GH release. This allows investigators to study how short bursts of GH signaling affect downstream pathways such as recovery, metabolic regulation, and adaptive response to physical stress.

Because it activates the native GH pathway rather than supplying external hormone, CJC-1295 without DAC is commonly selected in controlled endocrine research focused on physiologic regulation, feedback mechanisms, and short-duration signaling effects.

Commonly Explored For (Research Use Only)

• Growth hormone signaling and pulsatility research models

• Hypothalamic–pituitary axis function studies

• Recovery and post-stress endocrine response research

• Performance and training-adaptation signaling

• Metabolic and body-composition pathway